Canterbury, United Kingdom

Melanie Glossop

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Coave Therapeutics. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melanie Glossop. Retrieved from https://idiyas.com/inventor/melanie-glossop-c1tt8q0m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Melanie Glossop

Introduction

Melanie Glossop is a prominent inventor based in Canterbury, GB. She has made significant contributions to the field of biotechnology, particularly in the development of viral vectors for gene therapy. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Melanie holds a patent for "Lactam-Modified Adeno-Associated Virus Vectors." This innovative technology has the potential to enhance the efficacy of gene delivery systems, making it a valuable asset in therapeutic applications.

Career Highlights

Throughout her career, Melanie has demonstrated exceptional expertise in her field. She is currently employed at Coave Therapeutics, where she continues to push the boundaries of scientific research and innovation. Her dedication to her work has earned her recognition among her peers.

Collaborations

Melanie collaborates with talented individuals such as Nicolas Ferry and Karl Gibson. Together, they contribute to groundbreaking research that aims to transform the landscape of gene therapy.

Conclusion

In summary, Melanie Glossop is an influential inventor whose work in biotechnology is paving the way for future advancements in gene therapy. Her contributions are vital to the ongoing evolution of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…